866-997-4948(US-Canada Toll Free)

Prometheon Pharma, LLC - Product Pipeline Review - 2016

Published By :

Global Markets Direct

Published Date : Oct 2016

Category :

Pharmaceutical

No. of Pages : 32 Pages

Prometheon Pharma, LLC - Product Pipeline Review - 2016

Summary

Global Markets Directs, Prometheon Pharma, LLC - Product Pipeline Review - 2016, provides an overview of the Prometheon Pharma, LLCs pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Prometheon Pharma, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Prometheon Pharma, LLC
- The report provides overview of Prometheon Pharma, LLC including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Prometheon Pharma, LLCs pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Prometheon Pharma, LLCs out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Prometheon Pharma, LLCs strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Prometheon Pharma, LLC
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Prometheon Pharma, LLCs pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Prometheon Pharma, LLC Snapshot 5
Prometheon Pharma, LLC Overview 5
Key Facts 5
Prometheon Pharma, LLC - Research and Development Overview 6
Key Therapeutic Areas 6
Prometheon Pharma, LLC - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
Prometheon Pharma, LLC - Pipeline Products Glance 12
Prometheon Pharma, LLC - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Prometheon Pharma, LLC - Drug Profiles 14
(measles + mumps + rubella) vaccine - Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
diphtheria vaccine - Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
Drug to Agonize GLP-1 for Type I and Type II Diabetes - Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
Drug to Inhibit DPP-1 for Type I and Type II Diabetes - Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
Drug to Inhibit SGLT-2 for Type I and Type II Diabetes - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
insulin human - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
pneumococcal vaccine - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Protein to Agonize Insulin Like Growth Factor 1 Receptor for Hormone Replacement Therapy - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
sertraline hydrochloride - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Small Molecules to Inhibit TRIP-Br2 for Obesity and Insulin Resistance - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
somatropin - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
tetanus vaccine - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
Prometheon Pharma, LLC - Pipeline Analysis 26
Prometheon Pharma, LLC - Pipeline Products by Target 26
Prometheon Pharma, LLC - Pipeline Products by Route of Administration 27
Prometheon Pharma, LLC - Pipeline Products by Molecule Type 28
Prometheon Pharma, LLC - Pipeline Products by Mechanism of Action 29
Prometheon Pharma, LLC - Locations And Subsidiaries 30
Head Office 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 31
Disclaimer 32

List of Tables
Prometheon Pharma, LLC, Key Facts 5
Prometheon Pharma, LLC - Pipeline by Indication, 2016 8
Prometheon Pharma, LLC - Pipeline by Stage of Development, 2016 9
Prometheon Pharma, LLC - Monotherapy Products in Pipeline, 2016 10
Prometheon Pharma, LLC - Combination Treatment Modalities in Pipeline, 2016 11
Prometheon Pharma, LLC - Preclinical, 2016 12
Prometheon Pharma, LLC - Discovery, 2016 13
Prometheon Pharma, LLC - Pipeline by Target, 2016 26
Prometheon Pharma, LLC - Pipeline by Route of Administration, 2016 27
Prometheon Pharma, LLC - Pipeline by Molecule Type, 2016 28
Prometheon Pharma, LLC - Pipeline Products by Mechanism of Action, 2016 29

List of Figures
Prometheon Pharma, LLC - Pipeline by Top 10 Indication, 2016 7
Prometheon Pharma, LLC - Pipeline by Stage of Development, 2016 9
Prometheon Pharma, LLC - Monotherapy Products in Pipeline, 2016 10
Prometheon Pharma, LLC - Pipeline by Target, 2016 26
Prometheon Pharma, LLC - Pipeline by Route of Administration, 2016 27
Prometheon Pharma, LLC - Pipeline by Molecule Type, 2016 28
Prometheon Pharma, LLC - Pipeline Products by Mechanism of Action, 2016 29

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *